Experts from the Tradeoffs Advisory Board share some of their favorite new health policy studies.
Medicare
Posted inCost of Care
What to Expect When Medicare and Pharma Finally Negotiate Drug Prices
We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.
Posted inCost of Care
Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Posted inInsurance
One Economist’s Plan to Blow Up America’s Health Insurance System
Economist Amy Finkelstein has studied America’s patchwork of health insurance policies for more than 20 years. She’s finally concluded that it’s time to tear the whole system down.
Posted inHealth Equity
Putting a Price Tag on Patients’ Social Needs
A study in JAMA Internal Medicine calculates the cost of fully meeting the social needs of primary care patients – and finds the current system falls short.
Posted inInsurance
The Meteoric Rise of Private Medicare Advantage Insurance
What’s gained and what’s lost as private insurers manage an increasingly large share of the Medicare program?
Posted inPublic Health
What the PHE Taught Us About Sick Leave, Telemedicine and Public Health Powers
A trio of studies help mark the end of the PHE, and recap some of the health policy lessons learned from this unprecedented period.
Posted inCost of Care
The Wonky Policy That’s Got Hospitals on High Alert
Medicare could soon pay hospitals much less for common outpatient services like x-rays and checkups.
Posted inCost of Care
Hospice Care’s Midlife Crisis
Medicare is testing some major changes to its 40-year-old hospice benefit.
Posted inPublic Health
When Home Becomes a Hospital
What have we learned from the pandemic-feuled expansion of hospital-at-home care?